If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Mounjaro™ (tirzepatide) injection
2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Tirzepatide: Use in Patients With Hypothyroidism or Hyperthyroidism
Tirzepatide has not been studied in patients with hypothyroidism or hyperthyroidism.
There is no information on the use of tirzepatide in people with hypothyroidism or hyperthyroidism because this has not been studied. People with controlled endocrine abnormalities were not excluded from tirzepatide clinical trials. However, patients were excluded if they had a significant, uncontrolled endocrine abnormality (for example, thyrotoxicosis or adrenal crises) in the opinion of the investigator.
Date of Last Review: February 05, 2021